Profile data is unavailable for this security.
About the company
Level Bio AB (publ), formerly Alphahelix Molecular Diagnostics publ AB, is a Sweden-based company active in medical technology. The Company conducts research and development of patented technology that enables the identification of viruses and bacteria. Level Bio is the parent company in the group, with operations in the subsidiaries CyberGene and Techtum Lab. CyberGene develops and manufactures diagnostic kits for the clinical market. Techtum Lab is a reputable distributor and full-service partner to molecular biology labs in the Nordics. The products are sold under several brands and via its own distributors, mainly to laboratories and research institutes. The biggest activity is found within the Nordic market. The head office is in Nacka.
- Revenue in SEK (TTM)30.39m
- Net income in SEK-3.81m
- Incorporated1998
- Employees10.00
- LocationLevel Bio AB (publ)Fannys Vag 5NACKA 131 54SwedenSWE
- Phone+46 18120701
- Websitehttps://levelbio.se/
More ▼
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Bio Vitos Pharma AB | 191.53k | -20.07m | 4.73m | 1.00 | -- | 0.297 | -- | 24.69 | -0.4841 | -0.4841 | 0.005 | 0.4041 | 0.0076 | 0.0942 | 0.299 | 191,530.00 | -79.90 | -44.87 | -82.20 | -47.26 | -1,131.93 | 225.59 | -10,478.24 | -1,255.50 | 0.5737 | -- | 0.00 | -- | -96.31 | -- | -55.97 | -- | -- | -- |
| S2Medical AB (publ) | 18.87m | -996.45k | 9.17m | 17.00 | -- | 0.4561 | 26.22 | 0.4858 | -0.0012 | -0.0012 | 0.0224 | 0.0224 | 0.8658 | 0.516 | 12.92 | -- | -4.57 | -56.60 | -6.87 | -104.62 | 95.30 | 69.19 | -5.28 | -138.46 | 0.5176 | -39.17 | 0.00 | -- | 110.53 | 36.49 | 121.19 | -- | -- | -- |
| Inhalation Sciences Sweden AB | 3.24m | -9.93m | 10.65m | 6.00 | -- | 1.08 | -- | 3.29 | -0.4092 | -0.4092 | 0.1154 | 0.2529 | 0.2597 | 0.1161 | 3.10 | 539,666.70 | -79.64 | -30.98 | -98.54 | -45.83 | 89.22 | 75.78 | -306.67 | -47.68 | 4.70 | -521.63 | 0.003 | -- | -36.89 | 4.30 | -8.49 | -- | -- | -- |
| Level Bio AB (publ) | 30.39m | -3.81m | 20.29m | 10.00 | -- | 12.65 | -- | 0.6676 | -0.0591 | -0.0591 | 0.4585 | 0.0253 | 2.14 | 5.39 | 6.09 | 2,762,668.00 | -26.91 | -12.66 | -90.94 | -20.48 | 31.86 | -- | -12.55 | -8.37 | 0.6469 | -46.81 | 0.22 | -- | -3.83 | 7.86 | 16.92 | -- | -- | -- |
| VibroSense Dynamics AB | 2.00m | -4.75m | 25.81m | -- | -- | 2.89 | -- | 12.90 | -0.1611 | -0.1611 | 0.0675 | 0.2727 | 0.1634 | -0.6475 | 10.10 | -- | -38.77 | -49.73 | -45.60 | -58.13 | 128.95 | 98.07 | -237.28 | -389.04 | 4.85 | -- | 0.00 | -- | 3.00 | 12.37 | 36.76 | -- | -2.92 | -- |
| Invent Medic Sweden AB | 7.70m | -6.55m | 26.43m | 7.00 | -- | 4.07 | -- | 3.43 | -0.0574 | -0.0574 | 0.0677 | 0.0587 | 0.757 | 2.96 | 4.25 | 962,928.80 | -64.32 | -93.16 | -140.86 | -121.28 | 77.71 | 77.38 | -84.97 | -305.62 | 1.07 | -4.70 | 0.1265 | -- | 9.51 | 63.94 | 10.32 | -- | -7.72 | -- |
| SensoDetect AB | 1.31m | -9.49m | 26.53m | 2.00 | -- | 1.64 | -- | 20.19 | -0.0249 | -0.0249 | 0.0033 | 0.0366 | 0.0944 | -11.78 | 1,314.00 | 657,000.00 | -68.15 | -- | -79.20 | -- | 160.50 | -- | -722.22 | -- | 2.60 | -315.33 | 0.00 | -- | 375.00 | -- | -17.81 | -- | -- | -- |
| NanoEcho AB (publ) | 488.00k | -15.36m | 32.41m | 6.00 | -- | 0.7575 | -- | 66.42 | -0.0645 | -0.0645 | 0.0019 | 0.0609 | 0.0214 | -- | 1.46 | 61,000.00 | -67.27 | -- | -75.82 | -- | 994.67 | -- | -3,147.54 | -- | -- | -19.34 | 0.00 | -- | -- | -- | -4.93 | -- | -- | -- |
| Codelab Capital AS | -93.93bn | -93.93bn | 33.40m | 28.00 | -- | 1.10 | -- | -- | -- | -- | -- | 2.25 | -- | -- | -- | -- | -- | -10.24 | -- | -11.34 | -- | 83.77 | -- | -64.81 | -- | -- | 0.00 | -- | -99.58 | -70.67 | -602.25 | -- | -22.77 | -- |
| Qlife Holding AB | 290.00k | -6.28m | 34.49m | 5.00 | -- | -- | -- | 118.95 | -0.4088 | -3.03 | 0.0351 | -0.336 | 0.023 | 5.09 | 30.53 | 290,000.00 | -49.72 | -61.64 | -103.82 | -89.60 | -4,222.41 | -36.54 | -2,166.55 | -444.40 | 0.5089 | -- | 2.61 | -- | -79.51 | -- | 76.60 | -- | -- | -- |
| Perpetua Medical AB (publ) | 13.57m | 3.96m | 34.91m | 11.00 | 4.66 | 4.67 | 6.45 | 2.57 | 0.8754 | 0.8754 | 3.00 | 0.8731 | 0.4046 | 13.04 | 3.87 | 4,522,697.00 | 11.65 | -71.55 | 19.36 | -91.64 | 4.34 | -49.08 | 28.80 | -180.67 | 2.28 | 8.72 | 0.4216 | -- | -30.16 | 26.04 | 86.47 | -- | -32.00 | -- |
| Miris Holding AB (publ) | 19.52m | -3.93m | 41.30m | 9.00 | -- | 1.92 | -- | 2.12 | -8.82 | -8.82 | 34.34 | 16.18 | 0.7033 | 1.00 | 4.79 | 1,952,100.00 | -14.15 | -49.33 | -20.65 | -97.47 | 85.03 | 90.68 | -20.12 | -74.98 | 2.20 | -3.02 | 0.00 | -- | 13.56 | 8.35 | 53.96 | -- | 8.55 | -- |
Data as of Feb 13 2026. Currency figures normalised to Level Bio AB (publ)'s reporting currency: Swedish Krona SEK
0.03%Per cent of shares held by top holders
| Holder | Shares | % Held |
|---|---|---|
| Nordea Investment Management ABas of 31 Oct 2025 | 17.84k | 0.03% |
Data from 31 Dec 2025 - 31 Dec 2025Source: FactSet Research Systems Inc.
